The video will auto-play soon8Cancel
Play now
Want Stoke-on-Trent news emailed to you direct from our journalists? Sign up to our newsletterInvalid EmailSomething went wrong, please try again later.
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
The makers of Channel 5 s 999: Critical Condition are set to return to Stoke-on-Trent s main hospital to film a new series next month.
Film crews are expected to begin filming series three at the Royal Stoke University Hospital in June - and it will return to our screens later this year.
Biocon to deliver advanced cancer therapies across 30 countries
Biocon to deliver advanced cancer therapies across 30 countries
05 February 2021 | News
Image Credit: shutterstock.com
Biocon Biologics Ltd, a fully integrated ‘pure play’ biosimilars company and a subsidiary of Biocon Ltd has signed an agreement with the Clinton Health Access Initiative (CHAI) to expand access to lifesaving cancer biosimilars in over 30 countries in Africa and Asia as a part of the Cancer Access Partnership (CAP). The partnership is a significant step in delivering advanced cancer therapies to patients who need them the most and ensuring equitable access to high-quality biosimilars in low- and middle-income countries (LMICs).
Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries
Posted On: 2021-02-04 04:58:01 (Time Zone: Arizona, USA)
Biocon Biologics Ltd., a fully integrated pure play biosimilars company and a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), has signed an agreement with the Clinton Health Access Initiative (CHAI) to expand access to lifesaving cancer biosimilars in over 30 countries in Africa and Asia as a part of the Cancer Access Partnership (CAP). The partnership is a significant step in delivering advanced cancer therapies to patients who need them the most and ensuring equitable access to high-quality biosimilars in low- and middle-income countries (LMICs).
Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said it has signed a pact with the Clinton Health Access Initiative (CHAI) to expand access to life-saving cancer biosimilars in over 30 countries in Africa and Asia as a part of the Cancer Access Partnership. The partnershipis a significant step in delivering advanced cancer therapies to patients who need them themost and ensuring equitable access to high-quality biosimilars in low- and middle-incomecountries (LMICs), Biocon Biologics said in a statement.
Biocon Biologics willinitially supply biosimilar Trastuzumab and biosimilar Pegfilgrastim and will expand the arrangement to includeother biosimilars,it added. Biocon Biologics Executive ChairpersonKiran Mazumdar-Shaw said, The collaboration with CHAI further strengthens our resolve to address the unmet patient needs in Asia and Africa for advanced cancer therapies through cost effective alternatives to expensive reference biologics.
Pic: Google OLDBURY school has closed to all pupils today - shortly after closing to two year groups due to staff self-isolating. Perryfields High put out a letter to parents today stating that it been forced to close to all pupils because it had no hot water or heating due to a boiler tank leaking diesel. Yesterday (Monday December 14) the school sent a letter to parents stating it was closing to years eight and nine from today (Tuesday December 15) until the end of term due to the numbers of staff self-isolating. The letter from headteacher Ian Barton states: We are closely monitoring the absence of students and staff who need to self-isolate.